Dr. Desheng Hu 胡德胜
Chief Physician
Department of Radiation Oncology, Hubei Cancer Hospital, Wuhan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of lung cancer, head and neck tumors, colorectal cancer, breast cancer, and prostate cancer using radiotherapy and chemotherapy.
Dr. Hu is Deputy Director of Radiotherapy and Vice President at Hubei Cancer Hospital. A graduate of Hunan Medical University (1987) and master’s supervisor at Wuhan University, Dr. Hu has over 20 years of experience in oncology. The doctor introduced 3D conformal radiotherapy in Central China in 1999 and intensity-modulated radiotherapy for nasopharyngeal, prostate, and breast cancers since 2005.
Professional roles
- Member, Chinese Medical Association
Name order: in Chinese the family name comes first (Hu Desheng). Papers usually list the name as Desheng Hu or Hu D.
Selected publications
60 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Biochem Cell Biol, 2021 (senior author): JARID2 promotes stemness and cisplatin resistance in non-small cell lung cancer via upregulation of Notch1. PubMed 34246759
- Chin J Cancer Res, 2020 (senior author): Phase II study of induction chemotherapy followed by concurrent chemoradiotherapy with raltitrexed and cisplatin in locally advanced nasopharyngeal carcinoma. PubMed 33223761
- Cancer Cell Int, 2020 (senior author): lncRNA LIFR-AS1 suppresses invasion and metastasis of non-small cell lung cancer via the miR-942-5p/ZNF471 axis. PubMed 32489316
- Quant Imaging Med Surg, 2018 (senior author): Analysis of geometric variation of neck node levels during image-guided radiotherapy for nasopharyngeal carcinoma: recommended planning margins. PubMed 30211031
- Mol Clin Oncol, 2016 (senior author): Metastatic nerve root tumor: A case report and literature review. PubMed 27284440
- Quant Imaging Med Surg, 2016 (senior author): The tumor shape changes of nasopharyngeal cancer during chemoradiotherapy: the estimated margin to cover the geometrical variation. PubMed 27190763
- Future Oncol, 2014 (senior author): Sparing functional anatomical structures during intensity-modulated radiotherapy: an old problem, a new solution. PubMed 23987920
- Onco Targets Ther, 2013 (senior author): Target volume and position variations during intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. PubMed 24311943
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion